The MAP1B Binding Domain of Na1.6 Is Required for Stable Expression at the Axon Initial Segment.

J Neurosci

Molecular, Cellular and Integrative Neurosciences Graduate Program, Colorado State University, Fort Collins, Colorado 80523,

Published: May 2019

Na1.6 () is a major voltage-gated sodium channel in the mammalian CNS, and is highly concentrated at the axon initial segment (AIS). As previously demonstrated, the microtubule associated protein MAP1B binds the cytoplasmic N terminus of Na1.6, and this interaction is disrupted by the mutation p.VAVP(77-80)AAAA. We now demonstrate that this mutation results in WT expression levels on the somatic surface but reduced surface expression at the AIS of cultured rat embryonic hippocampal neurons from both sexes. The mutation of the MAP1B binding domain did not impair vesicular trafficking and preferential delivery of Na1.6 to the AIS; nor was the diffusion of AIS inserted channels altered relative to WT. However, the reduced AIS surface expression of the MAP1B mutant was restored to WT levels by inhibiting endocytosis with Dynasore, indicating that compartment-specific endocytosis was responsible for the lack of AIS accumulation. Interestingly, the lack of AIS targeting resulted in an elevated percentage of persistent current, suggesting that this late current originates predominantly in the soma. No differences in the voltage dependence of activation or inactivation were detected in the MAP1B binding mutant relative to WT channel. We hypothesize that MAP1B binding to the WT Na1.6 masks an endocytic motif, thus allowing long-term stability on the AIS surface. This work identifies a critical and important new role for MAP1B in the regulation of neuronal excitability and adds to our understanding of AIS maintenance and plasticity, in addition to identifying new target residues for pathogenic mutations of Na1.6 is a major voltage-gated sodium channel in human brain, where it regulates neuronal activity due to its localization at the axon initial segment (AIS). Na1.6 mutations cause epilepsy, intellectual disability, and movement disorders. In the present work, we show that loss of interaction with MAP1B within the Na1.6 N terminus reduces the steady-state abundance of Na1.6 at the AIS. The effect is due to increased Na1.6 endocytosis at this neuronal compartment rather than a failure of forward trafficking to the AIS. This work confirms a new biological role of MAP1B in the regulation of sodium channel localization and will contribute to future analysis of patient mutations in the cytoplasmic N terminus of Na1.6.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538857PMC
http://dx.doi.org/10.1523/JNEUROSCI.2771-18.2019DOI Listing

Publication Analysis

Top Keywords

map1b binding
16
axon initial
12
initial segment
12
sodium channel
12
ais
12
na16
11
map1b
9
binding domain
8
na16 major
8
major voltage-gated
8

Similar Publications

Microtubule-associated protein, MAP1B, encodes functionally distinct polypeptides.

J Biol Chem

November 2024

Department of Molecular and Cellular Biology, University of California, Davis, California, USA. Electronic address:

Microtubule-associated protein, MAP1B, is crucial for neuronal morphogenesis and disruptions in MAP1B function are correlated with neurodevelopmental disorders. MAP1B encodes a single polypeptide that is processed into discrete proteins, a heavy chain (HC) and a light chain (LC); however, it is unclear if these two chains operate individually or as a complex within the cell. In vivo studies have characterized the contribution of MAP1B HC and LC to microtubule and actin-based processes, but their molecular mechanisms of action are unknown.

View Article and Find Full Text PDF

FMRP regulates postnatal neuronal migration via MAP1B.

Elife

May 2024

Sorbonne Université, CNRS UMR8246, Inserm U1130, Institut de Biologie Paris Seine (IBPS), Neuroscience Paris Seine (NPS), Paris, France.

Article Synopsis
  • Fragile X syndrome (FXS) is the most common inherited intellectual disability and a leading genetic cause of autism, linked to a lack of the protein FMRP.
  • Research using mice lacking FMRP shows that its absence causes delays and changes in neuron movement during brain development, along with issues in centrosome positioning.
  • Targeting the mRNA for MAP1B can correct these migration issues, suggesting that FMRP and MAP1B work together to manage the microtubule structure critical for proper neuronal migration.
View Article and Find Full Text PDF

Emerging evidence indicates that arginine methylation promotes the stability of arginine-glycine-rich (RGG) motif-containing RNA-binding proteins (RBPs) and regulates gene expression. Here, we report that post-translational modification of FXR1 enhances the binding with mRNAs and is involved in cancer cell growth and proliferation. Independent point mutations in arginine residues of FXR1's nuclear export signal (R386 and R388) and RGG (R453, R455 and R459) domains prevent it from binding to RNAs that form G-quadruplex (G4) RNA structures.

View Article and Find Full Text PDF

RNA-binding proteins (RBPs) contribute to the pathogenesis of proliferative diabetic retinopathy (PDR) by regulating gene expression through alternative splicing events (ASEs). However, the RBPs differentially expressed in PDR and the underlying mechanisms remain unclear. Thus, this study aimed to identify the differentially expressed genes in the neovascular membranes (NVM) and retinas of patients with PDR.

View Article and Find Full Text PDF

Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.

Handb Clin Neurol

March 2024

Department of Neurology, Mayo Clinic, Rochester, MN, United States; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Electronic address:

Article Synopsis
  • Peripheral neuropathy is a significant reason patients are referred to neurologic clinics, with paraneoplastic neuropathies being a severe subgroup that can lead to high morbidity and mortality.
  • Symptoms often include weakness, sensory loss, autonomic dysfunction, severe constipation, and pain, and these neuropathies may be the first sign of underlying malignancy in patients.
  • Identifying specific antibodies can help target cancer investigations, as well as differentiate between various types of neuropathies, emphasizing the importance of testing for multiple antibodies simultaneously for better diagnostic sensitivity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!